Early research (Phase 1)Study completedNCT02893488
What this trial is testing
Relative Bioavailability Study of a Fixed-dose Combination Dolutegravir/Abacavir/Lamivudine Dispersible Tablet
Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 20